Scholar Rock withdraws Europe filing for muscle weakness drug, plans resubmission

Aug 21 (Reuters) – Scholar Rock said on Friday it withdrew its European application for the experimental spinal muscular atrophy drug and plans to resubmit it with a different manufacturing site after

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)